Products - Ear, nose and throat conditions | Topic | NICE

Showing 6 products

Date | Sort by Title

Guidance programme: Technology appraisal guidanceRemove ‘Guidance programme: Technology appraisal guidance’ filter

Cochlear implants for children and adults with severe to profound deafness (TA566)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
7 March 2019
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome (TA139)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
26 March 2008
Pitolisant hydrochloride for treating obstructive sleep apnoea ID1065
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
27 January 2021
Dupilumab for treating chronic rhinosinusitis with nasal polyps ID1179
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
14 July 2021
STG320 for treating persistent allergic rhinitis caused by house dust mites (ID1278)
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Omalizumab for treating chronic rhinosinusitis with nasal polyps [ID1650]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC